196 related articles for article (PubMed ID: 32435858)
1. Development of Morin-Loaded Nanoemulsions Containing Various Polymers; Role of Polymers in Formulation Properties and Bioavailability.
Ikeuchi-Takahashi Y; Murata S; Murata W; Kobayashi A; Ishihara C; Onishi H
AAPS PharmSciTech; 2020 May; 21(5):150. PubMed ID: 32435858
[TBL] [Abstract][Full Text] [Related]
2. Influence of Polysorbate 60 on Formulation Properties and Bioavailability of Morin-Loaded Nanoemulsions with and without Low-Saponification-Degree Polyvinyl Alcohol.
Ikeuchi-Takahashi Y; Kobayashi A; Ishihara C; Matsubara T; Matsubara H; Onishi H
Biol Pharm Bull; 2018; 41(5):754-760. PubMed ID: 29709912
[TBL] [Abstract][Full Text] [Related]
3. Nanoemulsion improves the oral bioavailability of baicalin in rats: in vitro and in vivo evaluation.
Zhao L; Wei Y; Huang Y; He B; Zhou Y; Fu J
Int J Nanomedicine; 2013; 8():3769-79. PubMed ID: 24124365
[TBL] [Abstract][Full Text] [Related]
4. Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform.
Choudhury H; Gorain B; Karmakar S; Biswas E; Dey G; Barik R; Mandal M; Pal TK
Int J Pharm; 2014 Jan; 460(1-2):131-43. PubMed ID: 24239580
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization, and evaluation of antioxidant activity and bioavailability of a self-nanoemulsifying drug delivery system (SNEDDS) for buckwheat flavonoids.
Zhao Z; Cui X; Ma X; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1265-1274. PubMed ID: 33216131
[TBL] [Abstract][Full Text] [Related]
6. Characterisation, in-vitro and in-vivo evaluation of valproic acid-loaded nanoemulsion for improved brain bioavailability.
Tan SF; Kirby BP; Stanslas J; Basri HB
J Pharm Pharmacol; 2017 Nov; 69(11):1447-1457. PubMed ID: 28809443
[TBL] [Abstract][Full Text] [Related]
7. Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies.
Parikh RH; Patel RJ
Curr Drug Deliv; 2016; 13(7):1130-1143. PubMed ID: 26638977
[TBL] [Abstract][Full Text] [Related]
8. Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats.
Gorain B; Choudhury H; Kundu A; Sarkar L; Karmakar S; Jaisankar P; Pal TK
Colloids Surf B Biointerfaces; 2014 Mar; 115():286-94. PubMed ID: 24388859
[TBL] [Abstract][Full Text] [Related]
9. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
10. Improved oral bioavailability of repaglinide, a typical BCS Class II drug, with a chitosan-coated nanoemulsion.
Karami Z; Saghatchi Zanjani MR; Nasihatsheno N; Hamidi M
J Biomed Mater Res B Appl Biomater; 2020 Apr; 108(3):717-728. PubMed ID: 31187938
[TBL] [Abstract][Full Text] [Related]
11. Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations.
Vyas TK; Shahiwala A; Amiji MM
Int J Pharm; 2008 Jan; 347(1-2):93-101. PubMed ID: 17651927
[TBL] [Abstract][Full Text] [Related]
12. Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.
Rajpoot P; Bali V; Pathak K
Int J Pharm; 2012 Apr; 426(1-2):219-230. PubMed ID: 22301424
[TBL] [Abstract][Full Text] [Related]
13. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.
Parveen R; Baboota S; Ali J; Ahuja A; Vasudev SS; Ahmad S
Int J Pharm; 2011 Jul; 413(1-2):245-53. PubMed ID: 21549187
[TBL] [Abstract][Full Text] [Related]
14. Utilization of nanoemulsions to enhance bioactivity of pharmaceuticals, supplements, and nutraceuticals: Nanoemulsion delivery systems and nanoemulsion excipient systems.
Aboalnaja KO; Yaghmoor S; Kumosani TA; McClements DJ
Expert Opin Drug Deliv; 2016 Sep; 13(9):1327-36. PubMed ID: 26984045
[TBL] [Abstract][Full Text] [Related]
15. Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics.
Yang M; Gu Y; Yang D; Tang X; Liu J
J Nanobiotechnology; 2017 Dec; 15(1):88. PubMed ID: 29202753
[TBL] [Abstract][Full Text] [Related]
16. Development and bioavailability assessment of ramipril nanoemulsion formulation.
Shafiq S; Shakeel F; Talegaonkar S; Ahmad FJ; Khar RK; Ali M
Eur J Pharm Biopharm; 2007 May; 66(2):227-43. PubMed ID: 17127045
[TBL] [Abstract][Full Text] [Related]
17. Local sustained delivery of bupivacaine HCl from a new castor oil-based nanoemulsion system.
Rachmawati H; Arvin YA; Asyarie S; Anggadiredja K; Tjandrawinata RR; Storm G
Drug Deliv Transl Res; 2018 Jun; 8(3):515-524. PubMed ID: 29516407
[TBL] [Abstract][Full Text] [Related]
18. Nano composite emulsion for sustained drug release and improved bioavailability.
Sun W; Ma X; Wei X; Xu Y
Pharm Res; 2014 Oct; 31(10):2774-83. PubMed ID: 24752481
[TBL] [Abstract][Full Text] [Related]
19. Self-Nanoemulsifying Drug Delivery System of Coenzyme (Q10) with Improved Dissolution, Bioavailability, and Protective Efficiency on Liver Fibrosis.
Khattab A; Hassanin L; Zaki N
AAPS PharmSciTech; 2017 Jul; 18(5):1657-1672. PubMed ID: 27677262
[TBL] [Abstract][Full Text] [Related]
20. Effect of high-pressure homogenization on formulation of TPGS loaded nanoemulsion of rutin - pharmacodynamic and antioxidant studies.
Sharma S; Sahni JK; Ali J; Baboota S
Drug Deliv; 2015; 22(4):541-51. PubMed ID: 24625264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
